WEST PHARMACEUTICAL SVSC INC's ticker is and the CUSIP is 955306905. A total of 3 filers reported holding WEST PHARMACEUTICAL SVSC INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,951 | +1183.6% | 5,200 | +1200.0% | 0.00% | – |
| Q2 2023 | $152 | -97.7% | 400 | -97.9% | 0.00% | -100.0% |
| Q1 2023 | $6,513 | +592.1% | 18,800 | +370.0% | 0.01% | +500.0% |
| Q4 2022 | $941 | -99.9% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $984,000 | +225.8% | 4,000 | +300.0% | 0.00% | – |
| Q2 2022 | $302,000 | -81.1% | 1,000 | -74.4% | 0.00% | -100.0% |
| Q1 2022 | $1,601,000 | +70.7% | 3,900 | +95.0% | 0.00% | 0.0% |
| Q4 2021 | $938,000 | +2505.6% | 2,000 | +1900.0% | 0.00% | – |
| Q3 2021 | $36,000 | +2.9% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $35,000 | -94.8% | 100 | +316.7% | 0.00% | -100.0% |
| Q1 2021 | $676,000 | – | 24 | -38.5% | 0.00% | – |
| Q4 2020 | $0 | – | 39 | +225.0% | 0.00% | – |
| Q3 2020 | $0 | – | 12 | +500.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 2 | -60.0% | 0.00% | – |
| Q1 2020 | $76,000 | -91.6% | 5 | -91.7% | 0.00% | -100.0% |
| Q4 2019 | $901,000 | +430.0% | 60 | +400.0% | 0.00% | – |
| Q3 2019 | $170,000 | +126.7% | 12 | +100.0% | 0.00% | – |
| Q2 2019 | $75,000 | +92.3% | 6 | +50.0% | 0.00% | – |
| Q4 2018 | $39,000 | -90.2% | 4 | -90.0% | 0.00% | -100.0% |
| Q2 2018 | $397,000 | – | 40 | +300.0% | 0.00% | – |
| Q3 2017 | $0 | – | 10 | +900.0% | 0.00% | – |
| Q1 2017 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 45,400 | $13,728,000 | 0.01% |
| JPMORGAN CHASE & CO | 24,000 | $7,257,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 700 | $212,000 | 0.00% |
| SIMPLEX TRADING, LLC | 1,000 | $302,000 | 0.00% |